Public buyer
Mazowieckie Centrum Leczenia Chorób Płuc i Gruźlicy
Main sectors
Publishing rhythm
O
N
D
J
F
M
A
M
J
J
A
S
Publishes most in February and January. Next likely wave: January 2027.
- €110,653
- Typical contract value
- Median of the last 3 priced notices
Based on 168 notices over the last 24 months.
Top winners
- Formed Sp. z o.o. 2 contracts €875,310
- Tramco Sp. z o.o.; Roche Polska Sp. z o.o.; Genesis Pharm sp. z o.o.; Takieda Pharma sp. z o.o.; Lek S.A.; Amgen sp. z o.o.; Bialmed Sp. z o.o.; Urtica Sp. z o.o.; Salus International Sp. z o.o.; Asclepios SA 1 contract €4,558,406
- Urtica Sp. z o.o.; Tramco Sp. z o.o.; Komtur Polska Sp. z o. o.; Astra Zeneca Kft; Roche Polska Sp. z o.o.; Farmacol-Logistyka Sp. z o.o.; Salus International Sp. z o.o.; Asclepios SA; Jansen-Cilag Polska Sp. z o.o. 1 contract €3,176,101
- akquinet consulting sp. z o.o. 1 contract €2,115,300
- Olympus Polska Sp. z o.o. 1 contract €1,787,964